Schardt JS, Oubaid JM, Williams SC, Howard JL, Aloimonos CM, Bookstaver ML, Lamichhane TN, Sokic S, Liyasova MS, O'Neill M et al..  2017.  Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells.. Mol Pharm. 14(4):1047-1056.

Chinenov Y, Coppo M, Gupte R, Sacta MA, Rogatsky I.  2014.  Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages.. BMC Genomics. 15:656.

Wang H-Y, Ma CA, Zhao Y, Fan X, Zhou Q, Edmonds P, Uzel G, Oliveira JBosco, Orange J, Jain A.  2013.  Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.. Proc Natl Acad Sci U S A. 110(13):5127-32.

Loeb GB, Khan AA, Canner D, Hiatt JB, Shendure J, Darnell RB, Leslie CS, Rudensky AY.  2012.  Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting.. Mol Cell. 48(5):760-70.

Amprey JL, Späth GF, Porcelli SA.  2004.  Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani.. Infect Immun. 72(1):589-92.

Imamura T, Luedke CE, Vogt SK, Muglia LJ.  2000.  Oxytocin modulates the onset of murine parturition by competing ovarian and uterine effects.. Am J Physiol Regul Integr Comp Physiol. 279(3):R1061-7.